Sign Out
Posology: Pregnant individuals: A single dose of 0.5 mL should be administered between weeks 24 and 36 of gestation (see Precautions and Pharmacology: Pharmacodynamics under Actions).
Individuals 60 years of age and older: A single dose of 0.5 mL should be administered.
Paediatric population: The safety and efficacy of Abrysvo in children (from birth to less than 18 years of age) have not yet been established. Limited data are available in pregnant adolescents and their infants (see Pharmacology: Pharmacodynamics under Actions).
Method of administration: Abrysvo is for intramuscular injection into the deltoid region of the upper arm.
The vaccine should not be mixed with any other vaccines or medicinal products.
For instructions on reconstitution and handling of the medicinal product before administration, see Special precautions for disposal and other handling under Cautions for Usage.
Continue with Google